Efficacy of Green Tea Polyphenols on Myelodysplastic Syndromes: A Double-Blind Placebo-Controlled Phase II Randomised Clinical Trial
Phase 2
Recruiting
- Conditions
- myelodysplastic syndromes (MDS)Blood - Haematological diseases
- Registration Number
- ACTRN12612000808842
- Lead Sponsor
- The University of Western Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Newly diagnosed as MDS by WHO 2008 criteria; Age is 18 years or over; ECOG performance status less than or equal to 2; Protocol defined adequate hepatic and renal function; Willing to refrain from drinking any kind of tea for the duration of the study; Written informed consent; And intending to reside in the state during study period.
Exclusion Criteria
Lack of, or withdrawal of, informed consent; Significant hematological co-morbidities, hepatic failure, renal failure or severe cardiovascular disease; Pregnant or positive pregnancy test or child-bearing; Participation in another trial; Or history of any cancer.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method